Herantis Pharma Oyj: Managers' Transactions – Frans Wuite

Cision Publicerad: 13 May 2022 08:00

Herantis Pharma Plc

Company release 13 May 2022 at 9:00am EEST

Herantis Pharma Oyj - Managers' Transactions

____________________________________________

Person subject to the notification requirement

Name: Frans Wuite

Position: Chief Executive Officer

Issuer: Herantis Pharma Oyj

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 14848/5/4

____________________________________________

Transaction date: 2022-05-10

Venue not applicable

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: SUBSCRIPTION

Transaction details

(1): Volume: 2512 Unit price: 1.5 EUR

Aggregated transactions

(1): Volume: 2512 Volume weighted average price: 1.5 EUR

____________________________________________

Further information:

Julie Silber/Gabriela Urquilla

Tel: +46 (0)7 93 486 277/+46 (0)72-396 72 19

Certified Advisor: UB Securities Ltd, Finland: +358 9 25 380 225, Sweden: +358 40 5161400

Company website: www.herantis.com

Distribution:

Main media
www.herantis.com